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Cancer is driven by somatically acquired point
mutations and chromosomal rearrangements, con-
ventionally thought to accumulate gradually over
time. Using next-generation sequencing, we charac-
terize a phenomenon, which we term chromothripsis,
whereby tens to hundreds of genomic rearrange-
ments occur in a one-off cellular crisis. Rearrange-
ments involving one or a few chromosomes criss-
cross back and forth across involved regions,
generating frequent oscillations between two copy
number states. These genomic hallmarks are highly
improbable if rearrangements accumulate over time
and instead imply that nearly all occur during a single
cellular catastrophe. The stamp of chromothripsis
can be seen in at least 2%–3% of all cancers, across
many subtypes, and is present in 25% of bone
cancers. We find that one, or indeed more than
one, cancer-causing lesion can emerge out of the
genomic crisis. This phenomenon has important
implications for the origins of genomic remodeling
and temporal emergence of cancer.
INTRODUCTION
The textbook model of cancer development is of progression
through a series of increasingly disordered clinical and patholog-
ical phases (Stratton et al., 2009). For example, invasive
colorectal cancer often emerges from an antecedent benign
adenomatous polyp; cervical cancer proceeds through intraepi-
thelial neoplasia before breaching the basement membrane;multiplemyeloma frequently develops in individualswith a history
of benignmonoclonal plasma cell proliferation. Biologically, such
stepwise clinical progression is underpinned by successive
waves of clonal expansion as cells acquire the multiple genetic
changes required for a fully malignant phenotype. Mutations
are essentially random, occurring as independent events
throughout the lifespan of an individual, potentially accelerated
by exogenous carcinogens or DNA repair defects. Genetic
variation generates phenotypic variation across the cells of an
organ system, which are then subject to clonal selection
through Darwinian competition. Variants that enhance a cell’s
evolutionary fitness, so-called driver mutations, promote out-
growth of that clone and progression toward cancer (Stratton
et al., 2009). The prevailing dogma of cancer evolution is there-
fore one of ‘‘gradualism’’ in which acquisition of driver mutations
occurs cumulatively over years to decades, resulting in incre-
mental progression through increasingly malignant phenotypes
(Jones et al., 2008).
There are, however, examples in which a more ‘‘punctuated
equilibrium’’ evolutionary model may apply to development of
cancers. Genome-wide telomere attrition in somatic cells, for
example, may generate naked DNA ends that act as a nidus
for on-going genomic rearrangement (Bardeesy and DePinho,
2002; O’Hagan et al., 2002; Sahin and Depinho, 2010). End-to-
end chromosome fusions resulting from telomere loss can lead
to spiraling cycles of dsDNA breakage, aberrant repair and
further chromosomal damage in both daughter cells (Artandi
et al., 2000; Gisselsson et al., 2001). Iteration of this breakage
and repair process can lead to extensive genomic remodeling
in multiple competing subclones in only a few cell cycles (Bignell
et al., 2007). Under these scenarios, bursts of somatic mutation
may accrue in relatively short periods of chronological time.
Such genomic rearrangements can drive the development of
cancer through several mechanisms. They may result in copyCell 144, 27–40, January 7, 2011 ª2011 Elsevier Inc. 27
number changes, including deletion of tumor suppressor genes
and increased copy number (amplification) of genes promoting
malignant cellular processes. In addition, chromosomal rear-
rangements can juxtapose portions of coding sequence from
two genes in the same orientation, leading to oncogenic fusion
genes, or bring together an intact gene with the regulatory
machinery of another gene, causing dysregulated gene
expression.
Here, we describe multiple cancer samples in which tens to
hundreds of genomic rearrangements have been acquired in
a single catastrophic event, a phenomenon we have termed
chromothripsis (Greek, chromos for chromosome; thripsis, shat-
tering into pieces).We characterize the genomic hallmarks of this
process, its frequency across diverse cancers and how such
cataclysmic genome disruption can promote the development
of cancer.
RESULTS
Localized Genomic Rearrangement in a Patient
with Chronic Lymphocytic Leukemia
Advances in DNA sequencing have made it possible to identify
the majority of somatically acquired genetic variants in cancer
samples on a genome-wide basis (Ding et al., 2010; Mardis
et al., 2009; Pleasance et al., 2010a, 2010b; Shah et al., 2009).
In particular, paired-end sequencing allows discovery of
genomic rearrangements (Campbell et al., 2008, 2010; Stephens
et al., 2009), through sequencing both ends of 50–100 million
genomic DNA fragments per sample. Alignment of the paired-
end reads to the reference genome enables identification of
putative genomic rearrangements.
In a rearrangement screen of 10 patients with chronic lympho-
cytic leukemia (CLL), we identified one patient who had 42
somatically acquired genomic rearrangements involving the
long arm of chromosome 4 (Figures 1A and 1B and Table S1
available online). The positions of these rearrangements relative
to one another and to copy number changes on chromosome 4q
reveal some striking patterns. First, the rearrangements show
geographic localizationwithin the genome. Apart froma separate
13q deletion in this patient, all rearrangements are confined to
chromosome 4q and focal points on chromosomes 1, 12, and
15 (Figure 1C). This is different to the patterns of genomic
instability we have typically seen in breast, lung, or pancreatic
cancer where rearrangements tend to be either scattered
genome-wide or, if localized, are associated with substantial
genomic amplification (Campbell et al., 2008; Pleasance et al.,
2010b; Stephens et al., 2009). Second, the copy number profile
across the chromosome arm shows many positions at which
copy number changes, but these changes alternate between
just two states, namely one or two copies. Analysis of allelic
ratios at germline single nucleotide polymorphism (SNP) posi-
tions on chromosome 4q demonstrated that regions of copy
number 1 show loss of heterozygosity, but regions of copy
number 2 retain heterozygosity (data not shown). Third, the
many regions of copy number 1 are not caused by simple
deletions. Instead, a series of complex rearrangements spanning
the involved region generate the copy number changes, as can
be seen by the distribution of rearrangements falling at28 Cell 144, 27–40, January 7, 2011 ª2011 Elsevier Inc.change-points in copy number (Figure 1A). These have both in-
verted and noninverted orientation, with all four orientations of
intrachromosomal breakpoints represented in approximately
even numbers: deletion-type (8 rearrangements), tandem
duplication-type (9), head-to-head inverted (6), and tail-to-tail
inverted (10). Fourth, there is pronounced clustering of break-
points across the chromosome arm with, for example, seven
rearrangements involving the 30 kb region between 77.013 Mb
and 77.043 Mb, and six rearrangements in the 25 kb between
170.620 Mb and 170.645 Mb. Fifth, although the locations of
DNA breaks show clustering, the two conjoined fragments of
chromosome at each breakpoint are not geographically proxi-
mate. That is, there are as many rearrangements joining regions
of the chromosome normally separated by tens of megabases in
the germline as there are junctions between close-by regions.
Sixth, there are nine rearrangements joining the long arm of
chromosome 4 to other chromosomes—breakpoints on these
partner chromosomes also show clustering (Figure 1C).
The sample analyzed was collected from a 62-year-old
woman with CLL who had not previously received treatment.
Her subsequent clinical course showed rapid deterioration,
and she was treated with alemtuzumab, but unfortunately, she
relapsed quickly. To assess whether the abnormalities seen in
the pretreatment sample persisted in the relapsing cells or
indeed showed further evolution, we sequenced a relapse spec-
imen collected 31 months after the initial sample. All rearrange-
ments present in the pretreatment sample were present in the
later sample (Figures 1B–1D), and the striking copy number
profile persisted. Furthermore, there were no new genomic
rearrangements, suggesting that the process generating this
complex regional remodeling had resolved before the patient
was first diagnosed.
Complex Rearrangement of Single Chromosomes
Is Seen in At Least 2%–3% of All Cancers
To assess whether the unusual genomic landscape observed in
the patient with CLL could be seen in other cancer samples, we
analyzed high-resolution copy number profiles of 746 cancer cell
lines obtained using SNP arrays (Bignell et al., 2010). Of these, 96
cell lines have at least one chromosome with >50 positions at
which copy number changes (Figure S1A), many of which are
caused by amplicons or other complex clusters of rearrange-
ments. Notably, 18/746 (2.4%; 95% confidence interval, 1.5%–
3.9%) cell lines have copy number profiles similar to that seen
in the CLL patient, with frequent copy number changes confined
to localized genomic regions rapidly alternating between one,
two, or occasionally three different states (Figures S1B–S1T).
Copy number changes could involve the entire chromosome
(for example, SNU-C1, Figure S1G), a whole arm of a chromo-
some (SW982, Figure S1H), the telomeric portion of a chromo-
some (C32, Figure S1C), or an interstitial region of a chromosome
(A172, Figure S1D). The pattern was seen inmany different tumor
types, including melanoma (4 cell lines), small cell lung cancer
(3 cell lines), glioma (3 cell lines), hematological malignancies
(2 cell lines), nonsmall cell lung cancer (1 cell line), synovial
sarcoma (1 cell line), and esophageal (1 cell line), colorectal
(1 cell line), renal (1 cell line), and thyroid (1 cell line) cancers.
Furthermore, in segmented SNP array data from 2792 cancers,
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Figure 1. Clustered Rearrangements on Chromosome 4q in a Patient with Chronic Lymphocytic Leukemia
(A) Copy number between 70Mb and 170Mbof the chromosome oscillates between a copy number of 1 and 2, demarcated by back-and-forth intrachromosomal
rearrangements of all four possible orientations, as well as several interchromosomal rearrangements.
(B) PCR gel of 12 putative genomic rearrangements identified by sequencing. PCR across the breakpoint is performed for each rearrangement on tumor DNA for
samples taken at initial presentation (T1) and relapse (T2) as well as germline DNA (N).
(C) Genome-wide profile of rearrangements in a sample taken before chemotherapy. Chromosomes range round the outside of the circle, copy number changes
are shown by the blue line in the inner ring, and somatically acquired genomic rearrangements are shown as arcs linking the two relevant genomic points.
(D) Genome-wide profile of rearrangements from the same patient 31 months later, at relapse after therapy.of which 80% were primary tumors (Beroukhim et al., 2010), we
find evidence for chromothripsis in a similar proportion of cases
(Figure S1T).We selected four of these cell lines for further genomic analysis
with massively parallel paired-end sequencing for rearrange-
ments and cytogenetic studies: SNU-C1, 8505C, TK10, andCell 144, 27–40, January 7, 2011 ª2011 Elsevier Inc. 29
SCLC-21H (described later). In SNU-C1, derived from a colo-
rectal cancer, we identified 239 rearrangements involving
chromosome 15 (Figure 2A and Table S2). From 8505C, a thyroid
cancer line, we mapped 77 rearrangements involving the short
arm of chromosome 9 (Figure 2B and Table S2), and for TK10,
a renal cancer, 55 rearrangements involving chromosome 5
(Figure 2C and Table S2).
The distinctive genomic configuration observed in the CLL
patient is stamped on these three cell lines. Striking geographic
localization of rearrangements is evident in these samples.
Although a few rearrangements were observed elsewhere in
the genome (Figure S2), these are generally straightforward
events such as deletions or tandem duplications and do not
intersect with the regions of massive disruption shown in Fig-
ure 2. The localization is especially evident in 8505C (Figure 2B),
in which rearrangements only involve the telomeric portion of
chromosome 9p with sparing of the most centromeric bands of
9p and all 9q. As in the CLL patient, copy number oscillates
rapidly between two states, with the lower copy number state
showing loss of heterozygosity (LOH) and the higher copy
number state retaining heterozygosity.
One question that arises is whether the rearrangements are all
found on a single parental copy of the chromosome or whether
both copies are involved. We therefore performed spectral
karyotyping on the three cell lines (Figure 3A and Figure S3).
TK10, a hyperdiploid line, carries six copies of chromosome 5.
Consistent with the observed copy number profile alternating
between states of copy number 4 with LOH and copy number
6 with heterozygosity, the karyotype showed four grossly normal
copies of chromosome 5 and two smaller derivative chromo-
somes. Similarly, in 8505C, two copies of chromosome 9
showed distinctly foreshortened p arms alongside two cytoge-
netically normal chromosomes. None of the three karyotypes
indicated translocations involving the respective derivative chro-
mosomes, confirming the impression from the paired-end
sequencing data that the genomic remodeling of these regions
was entirely intrachromosomal. Cytogenetic changes were
consistently seen across all cells examined.
The spectral karyotypes suggest that the rearrangements
involve a single parental copy of the chromosome. To demon-
strate this further, we designed FISH probes to five widely
dispersed regions of chromosome 5 at copy number 6 in TK10
(Figure 3B). From the paired-end sequencing, we predicted
that the two regions at 6 Mb and 172 Mb would be joined by
a head-to-head inverted rearrangement, and the three regions
at 32 Mb, 66 Mb, and 150 Mb would be joined by another
head-to-head inverted rearrangement and a tandem duplica-
tion-type rearrangement. These FISH probes, labeled with
different dyes, were hybridized to TK10 cells (Figure 3C). As ex-
pected, there were four copies of chromosome 5 per cell
showing the correct genomic orientation and distribution of the
five probes. In addition, each cell carried two copies of a deriva-
tive 5 chromosome in which all five probes were closely juxta-
posed, as predicted by the sequencing data. These patterns
were seen identically across all cells examined.
Taken together, these data suggest that at least 2%–3% of
all cancers show evidence for massive remodeling of a single
chromosome, involving tens to hundreds of genomic rearrange-30 Cell 144, 27–40, January 7, 2011 ª2011 Elsevier Inc.ments. The consistency of cytogenetic findings across the many
cells examined implies that the clustering of genomic break-
points cannot be explained by multiple, parallel rearrangements
in different subclones. In the lines studied here, the genomic
remodeling occurred when there were just the two parental
copies of the relevant chromosome, preceding chromosomal
duplication events. This explains why copy number states alter-
nate between heterozygous and LOH and why more than one
copy of the derivative chromosome is present.
Chromothripsis Is Particularly Common in Bone
Cancers and Can Involve More Than One Chromosome
Alongside the rearrangement screen in CLL, we performed
rearrangement screens in primary tumor samples from 20
patients with bone cancer, including 9 with osteosarcoma and
11 with chordoma, a rare type of cancer arising in the spinal
column. Strikingly, five of these patients (25%; 95% confidence
interval, 10%–49%), three with osteosarcoma and two with
chordoma, also show large numbers of clustered rearrange-
ments with the hallmarks of chromothripsis.
In four of these five bone tumors, rearrangements affect
localized regions of several chromosomes (Figure 4, Figure S4,
Table S3, and Table S4). For example, we identified 147 somat-
ically acquired genomic rearrangements in a chordoma sample,
PD3808a, involving and linking together well-circumscribed
regions of chromosomes 3q, 4q, 7q, 8p, and 9p (Figure 4A).
Analogous to chromothripsis involving single chromosomes,
copy number in each of these chromosomal regions cycles
between two different states with retention of heterozygosity in
the higher copy number state. Of the 147 rearrangements, 49
are intrachromosomal and show the same back-and-forth
mixture of inverted and noninverted rearrangements described
above. The numerous interchromosomal rearrangements link
the various disrupted regions together, implying that the result-
ing genomic structure is a complex medley of fragments from
different chromosomes jumbled together.
In samples from three patients with osteosarcoma, PD3786a
(Figure 4B), PD3791a (Figure S4A), and PD3799a (Figure S4B),
we identified 88, 86 and 24 rearrangements respectively
with similar overall patterns of copy number change and rear-
rangement. PD3807a, another chordoma sample, also had 38
rearrangements interlinking well-defined regions of four chromo-
somes (Figure 4C). Clinically, the patients ranged in age from 9 to
64 years and four of the samples were from resections of treat-
ment-naive primary tumors, whereas one of the patients
(PD3786a) had previously received neoadjuvant chemotherapy.
In 1 of 13 pancreatic cancers we previously sequenced (Camp-
bell et al., 2010), we identified 41 rearrangements involving
chromosomes 1, 4, 10, and 14 with the hallmarks of chromo-
thripsis (Figure S4H), suggesting that involvement of multiple
chromosomes by this process is not restricted to bone tumors.
The Vast Majority of Chromothripsis Rearrangements
Occur in a Single Catastrophic Event
There are two potential models for how such complex restructur-
ing of a chromosome could develop. Under the progressive
rearrangement model, the rearrangements occur sequentially
and independently of one another over many cell cycles, leading
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Figure 2. Rearrangement Screens in Three Cancer Cell Lines Showing Evidence for Chromothripsis
Copy number profiles derive from SNP6 microarray data and are shown as the upper panel of points for each cell line. Allelic ratios for each SNP are shown in
the lower panel of dots: homozygous SNPs cluster at allelic ratios near 0 or 1, heterozygous SNPs cluster around 0.5. Intrachromosomal rearrangements of all
four possible orientations are shown, with deletion-type events as blue lines, tandem duplication-type in red, tail-to-tail inverted rearrangements in green and
head-to-head inverted rearrangements in yellow.
(A) SNU-C1, a cell line from a colorectal cancer, carries 239 rearrangements involving chromosome 15.
(B) 8505C, a thyroid cancer cell line, has 77 rearrangements involving chromosome 9p.
(C) TK10, a renal cancer cell line, has 55 rearrangements involving chromosome 5.
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(A) The spectral karyotype of the TK10 genome.
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(C) Multicolor FISH of TK10.to increasingly disordered genomic structure (Figure 5A). This is
the conventional view of how most complex regional clusters of
rearrangements evolve, especially genomic amplification. Local-
ization results either from rearrangement targeting a specific
cancer gene or through regional abnormalities driving recurrent
DNA breakage. The second model to explain the distinctive
genomic structures described here is that the overwhelming
majority of rearrangements occur in a single catastrophic event.32 Cell 144, 27–40, January 7, 2011 ª2011 Elsevier Inc.In this scenario, the chromosome or chromosomal region
shatters into tens to hundreds of pieces, some (but not all) of
which are then stitched together by the DNA repair machinery
in a mosaic patchwork of genomic fragments (Figure 5B).
Several characteristics of the patterns we observe here make
the progressive rearrangement model difficult to sustain, and
give support to the catastrophe model. The first observation is
that the number of copy number states observed in the final
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Figure 4. Chromothripsis Involving More Than One Chromosome in Primary Samples from Patients with Bone Cancer
For each case, the relevant chromosomes are shown with SNP6 microarray copy number profiles in the outer ring, allelic ratios in the inner ring, and somatically
acquired genomic rearrangements shown as arcs in the center.
(A) PD3808a, from a chordoma, shows 147 rearrangements interlinking chromosomes 3q, 4q, 7q, 8p, and 9p.
(B) PD3786a, an osteosarcoma sample, carries 88 rearrangements involving chromosome 8, 12, and 14.
(C) PD3807a, another chordoma sample, has 38 rearrangements involving chromosomes 1p, 3, 8, and 14.configuration of the chromosome is restricted to two (occasion-
ally three). With sequential, independent rearrangements, the
number of different states observed would be expected to
increase as the number of breakpoints rises (Figure 5A). Tandemduplications increase copy number and, because many of the
observed rearrangements with a tandem duplication pattern in
these samples overlap with one another, we would anticipate
a number of segments to have been sequentially amplifiedCell 144, 27–40, January 7, 2011 ª2011 Elsevier Inc. 33
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Figure 5. Genomic Features of Chromothripsis Suggest that Most Rearrangements Occur in a Single Catastrophic Event
(A) Example of a sequence of progressive rearrangements disrupting a model chromosome. The chromosomal configuration after each rearrangement is shown,
together with the copy number and rearrangement plot that would result (in the style of Figure 2).
(B) Example of how a chromosomal catastrophe might break the chromosome into many pieces that are then stitched back together haphazardly.
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number of copy number states seen in the resultant derivative chromosome. Samples with chromothripsis, shown as red diamonds, fall well outside this
spectrum.
(D) Observed distances between adjacent breakpoints for each sample are shown beside the expected distribution if breaks occurred in entirely random
locations.several-fold under the progressive rearrangements model.
Although deletion events would tend to counteract increases in
copy number, the chances of these two processes being so
balanced as to generate only two copy number states fall rapidly
as the number of rearrangements increases. To demonstrate
this, we performed Monte Carlo simulations of the progressive
rearrangement model. Rearrangements were randomly sampled
from the set of breakpoints found in SNU-C1, the resulting chro-
mosome structure calculated, and the process repeated to
generate different numbers of rearrangements (Figure 5C). As
predicted, with increasing numbers of rearrangements, the
observed number of different copy number states also rises.34 Cell 144, 27–40, January 7, 2011 ª2011 Elsevier Inc.The observed profiles of the three cell lines and the CLL patient
sit well outside the spectrum observed under simulations of the
progressive rearrangement model.
In contrast, the catastrophe model predicts exactly two copy
number states. Those fragments that are retained in the eventual
derivative chromosome will have the higher copy number state;
those that are lost to the cell will be in the lower copy number
state (Figure 5B).
The second problem for the progressive rearrangements
model is the retention of heterozygosity in regions with higher
copy number. Once lost, heterozygosity cannot generally be re-
gained. For example, the region around 66 Mb of chromosome
15 of SNU-C1 is heterozygous, but is encompassed in the span
of no fewer than 21 rearrangements with the orientation of
deletions, as well as 20 tandem duplication-type and 52 inverted
rearrangements (Figure 2A). Under the progressive rearrange-
ment model, a deletion that occurred early in the sequence of
rearrangements would permanently remove heterozygosity
between the breakpoints. Thus, deleting events can only occur
late in the succession of rearrangements, once regions of re-
tained heterozygosity have either been switched out of the
region by inversion or copied by tandem duplication. When
extended across all 239 rearrangements involving chromosome
15, there is major difficulty constructing a sequence of progres-
sive rearrangements that would spare the heterozygosity found
in over 20 separate segments. In contrast, alternating regions
of heterozygosity and LOH is the natural consequence of the
catastrophe model. With a normal parental chromosome and
one shattered into many pieces, any fragment that is retained
in the eventual derivative chromosome will be heterozygous;
those that are lost to the cell will result in LOH in those regions
(Figure 5B).
A third feature arguing against the progressive rearrangement
model is that breakpoints show significantly more clustering
along the chromosome or chromosome arm than expected by
chance (Figure 5D). A clean break across double-stranded
DNA (dsDNA) generates two naked ends of which none, one or
twomay subsequently be repaired. Some of the clustering repre-
sents erroneous repair of both sides of a dsDNA break (see
Figure 5B, for example). The extent of clustering observed in
breakpoint locations, however, is much greater than explicable
by this means alone. This presents some difficulties for the
progressive rearrangements model because such nonrandom
distribution of independently generated breaks would imply
extensive regional variation in chromosomal fragility. Specific
regions of increased propensity to rearrangement have been
documented (Bignell et al., 2010), but not to the extent observed
here. Under a catastrophe model, clustering among the prolific
numbers of DNA breaks would perhaps be expected, depending
on the process causing the DNA damage and repair. The limited
overlap between sequences at the breakpoint junction suggests
that the major mechanisms of DNA repair here are microhomol-
ogy-mediated break repair and/or nonhomologous end-joining
rather than homologous recombination (Figure S5).
In conclusion, several distinctive genomic features imply that
a major catastrophic event underpins the massive, but localized,
genomic rearrangement in these samples. These arguments
extend to cancers where we have observed involvement of
several different chromosomes. We do not argue that absolutely
every rearrangement was generated in one event—indeed,
a later partial duplication of the derivative chromosome is likely
to explain why some samples (such as C32, Figure S2C) oscillate
across three copy number states rather than two. However, the
majority of rearrangements seen in these examples almost
certainly occurred in a single event.
Chromothripsis Can Generate Genomic Consequences
that Promote Cancer Development
A cell suffering tens to hundreds of DNA breaks in a single cata-
clysmic event would be expected to undergo apoptosis. Thata cell can survive such an insult and progress to become
cancerous suggests that the extensive remodeling of the
genome may confer significant selective advantage to that
clone. To explore this possibility, we analyzed the genomic
data for evidence of changes that might promote the develop-
ment of cancer.
One small cell lung cancer cell line, SCLC-21H, demonstrates
massive numbers of copy number changes on chromosome 8,
mostly with the typical appearances of chromothripsis (Fig-
ure S2A). Interestingly, however, the SNP array data suggest
that some segments of the chromosome might be heavily
amplified. We mapped 170 breakpoints, all involving chromo-
some 8 and showing the expected patterns of rearrangements
described above (Figure 6A and Table S2). Whereas most of
the chromosome oscillates among low copy number states,
there are 15 discrete segments of the chromosome present at
markedly increased copy number, ranging from 50 to 200 copies
per cell (Figure 6B). One of these segments contains the MYC
oncogene, amplified in 10%–20% of small cell lung cancers
(Sher et al., 2008). The rearrangement data demonstrate that
the 15 regions are interwoven by a series of rearrangements,
many of which demarcate the starts and ends of the massively
amplified segments. Strikingly, we found no evidence for break-
points linking these massively amplified regions to the other,
nonamplified but rearranged, regions of chromosome 8.
One potential mechanism for these findings is that at some
stage while the cancer was evolving, chromosome 8 shattered
into hundreds of pieces. Many of these were stitched together
into a derivative chromosome 8, but 15 other fragments were
joined to create a double minute chromosome of 1.1Mb in
size (thick lines, Figure 6B). ContainingMYC, it was of consider-
able selective advantage for daughter cells to carry extra copies
of the double minute, and through further internal rearrange-
ments (thin lines, Figure 6B) and overreplication, the massive
amplification evolved.
To assess this hypothesis, we performed multicolor FISH.
First, we probed three nonamplified segments of chromosome
8 that the sequencing suggested were joined together through
a head-to-head inverted rearrangement and a tandem duplica-
tion-type rearrangement. This revealed a single normal copy of
chromosome 8 with the probes hybridized in the expected
orientation and distance apart, and two derivative 8 chromo-
somes with the three probes closely juxtaposed (Figure 6C).
Thus, the cells contain a cytogenetically normal chromosome 8
and a derivative chromosome 8 generated by chromothripsis
that has subsequently undergone chromosomal duplication.
Second, we probed three of the chromosome 8 regions that
were heavily amplified (Figure 6D). This demonstrated huge
numbers of extrachromosomal copies of the segments, with
the probes closely abutting. In addition, there were two homoge-
neously staining regions identified by the probes, consistent
with chromosomal integration of the double minutes. Probes
for the double minute chromosomes were found in the correct
orientation on the normal chromosome 8, but were absent from
the two copies of the derivative chromosome 8 (Figure S6A).
Taken together, these findings are consistent with the model
that the catastrophic shattering of chromosome 8 has facilitated
the creation of a double minute chromosome, which, in thisCell 144, 27–40, January 7, 2011 ª2011 Elsevier Inc. 35
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Figure 6. Generation of a Double Minute Chromosome ContainingMYC by Chromothripsis in a Small Cell Lung Cancer Cell Line, SCLC-21H
(A) Copy number profile, allelic ratio, and rearrangements of chromosome 8.
(B) Copy number data from the rearrangement screen shows 15 discrete regions of chromosome 8 that are massively amplified, with 50–200 copies per cell.
Each amplified region is demarcated by rearrangements linking to other heavily amplified segments (thick lines), with evidence for later internal rearrangements
also found (thin lines).
(C) Three color FISH for three regions of chromosome 8 (predicted to be linked by the rearrangement data, but not amplified; green, 13 Mb; red, 41 Mb;
pale pink, 49 Mb).
(D) FISH for three heavily amplified regions. The locations of the probes are shown in Figure 6B (red, 66.5 Mb; white, 99.3 Mb; green, 128.8 Mb).
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Figure 7. Loss of Tumor Suppressor Genes
through Chromothripsis
(A) PD3808a, the chordoma sample shown in
Figure 4A, shows clustered chromothripsis re-
arrangements around CDKN2A, leading to a loss
of one copy of this tumor suppressor gene. The
other copy is also lost, through a deletion, which
presumably occurred on the other parental copy of
chromosome 9p at a separate time-point (thick
line). The same cluster of chromothripsis re-
arrangements causes loss of a second tumor
suppressor gene, FBXW7, on chromosome 4q and
a third cancer gene, WRN, on chromosome 8p.
(B) Chromothripsis has also led to loss of one copy
of CDKN2A in the thyroid cancer cell line, 8505C.
(C) Loss of two tumor suppressor genes, CDKN2A
and the microRNA cluster miR-15a/16-1, by
clustered rearrangements involving chromosomes
4, 9, and 13 in a patient with CLL, PD3175a.example, containing MYC, acts as a substrate for amplification,
evolutionary selection and progression toward cancer.
Chromothripsis may lead to the generation of other forms of
marker chromosome also. We studied the spectral karyotype
of the pancreatic cancer sample with evidence for chromothrip-
sis involving multiple chromosomes (Figures S6B and S6C).
Even with the low resolution of SKY, a chromosome arm with
at least six cytogenetically visible stripes could be seen, indi-
cating that the many interchromosomal rearrangements have
intertwined segments from multiple different chromosomes
into a distinctive marker chromosome.
A second potential mechanism by which chromothripsis could
generate cancer-causing genomic changes is through loss or
disruption of tumor suppressor genes. In the chordoma,
PD3808a, the CDKN2A gene is homozygously deleted (Fig-
ure 7A), with one of the copies probably lost through chromo-
thripsis. The two rearrangements demarcating the copy number
change from 2 to 1 around CDKN2A (marked with * in Figure 7A)
appear to be part of the network of interchromosomal rearrange-
ments interlinking regions from chromosomes 3q, 4q, 7q, 8p,
and 9p seen in Figure 4A. This argues that loss of this copy ofCell 144, 27–the gene occurred during chromothripsis,
although it is formally possible that an
independent deletion of CDKN2A might
have occurred before chromothripsis.
The second copy of the gene was lost
through a focal deletion on the other
parental chromosome, which presumably
occurred as a temporally separate event
(thick blue line, Figure 7A).
With so many rearrangements gener-
ated in a single genomic crisis, it is
feasible that more than one cancer-
causing lesion could occur in the same
event. In addition to the loss of CDKN2A
described above, the chordoma sample
PD3808a had a rearrangement that
directly disrupted WRN, linking the 30portion of this gene on chromosome 8 to an intergenic region
on 9p just downstream of CDKN2A (thick purple line, Figure 7A).
WRN is a cancer gene in which germlinemutation causesWerner
syndrome, a condition associated with markedly increased risk
of bone tumors, and in which somatic inactivating mutations
have been documented in renal cancer (Dalgliesh et al., 2010).
This same patient also lost a copy of FBXW7 on chromosome
4q (Figure 7A). The rearrangements around this gene link to
chromosomes 3q, 7q, 8p, 9p, and elsewhere on 4q similar to
those near CDKN2A and WRN, suggesting that loss of FBXW7
occurred during the same chromothripsis event. FBXW7 is
inactivated in 6% of all cancers across many subtypes
(Akhoondi et al., 2007; Kemp et al., 2005; Maser et al., 2007).
Inactivation is frequently heterozygous, supported by functional
data suggesting it may be a haploinsufficient tumor suppressor
gene (Kemp et al., 2005; Mao et al., 2004). Thus, the single
catastrophic event inducing chromothripsis in this patient has
resulted in disruption of three tumor suppressor genes.
A number of other known cancer genes were affected by
rearrangements across the samples described here (Table S5),
including ARID1A in PD3807a (chordoma). In 8505C, the40, January 7, 2011 ª2011 Elsevier Inc. 37
chromothripsis involving chromosome 9p has led to loss of one
copy of CDKN2A (Figure 7B); the other carries a deletion of the
first exon of the gene. We also identified a second patient with
CLL who showed evidence for loss of two tumor suppressor
genes in a cluster of rearrangements involving chromosomes
4, 9, and 13 (Figure 7C). Here, single copies of both CDKN2A
and miR-15a/16-1, the microRNA cluster deleted in >50% of
CLL patients (Cimmino et al., 2005), were lost through interchro-
mosomal rearrangements, whereas the other copy of the micro-
RNA cluster was deleted in a presumably separate event (blue
line, Figure 7C).
Theoretically, chromothripsis rearrangements could juxtapose
coding portions of two genes in the same orientation with an
open reading frame, producing a potentially oncogenic fusion
gene. Among chromothripsis rearrangements, we found 17
that could potentially create novel in-frame fusions (Table S5).
None generates a classic cancer-associated fusion gene, such
as BCR-ABL1 or EWS-FLI1, and the proportion of rearrange-
ments generating novel in-frame fusions is similar to that
observed for other types of rearrangements (Campbell et al.,
2010; Stephens et al., 2009). This suggests that most are
coincidental ‘‘passenger’’ events, unlikely to drive cancer
development.
Such dramatic restructuring of a genome will disrupt both
coding sequences directly and the linkage between coding
exons and regulatory elements of verymany genes.We explored
whether expression profiles of genes from chromosomes
affected by chromothripsis differed from those of intact chromo-
somes. For SCLC-21H, genes from chromosomes that were not
affected by chromothripsis showed an approximately normal
distribution of expression levels relative to their expression in
other SCLC cell lines (Figure S7), as expected. On chromosome
8, however, affected by chromothripsis, expression levels were
decreased in 5% of genes in SCLC-21H relative to their
expression in other SCLC cell lines (chromosome 7 versus
chromosome 8, p = 0.001; chromosome 6 versus chromosome
8, p < 0.0001). Similar differences were observed for SNU-C1,
in which chromothripsis affected chromosome 15 (chromosome
14 versus chromosome 15, p = 0.02; chromosome 13 versus
chromosome 15, p < 0.0001).
Taken together, these data exemplify the mechanisms by
which chromothripsis can promote the development of cancer.
In particular, more than one cancer-causing lesion can arise
from a single catastrophe, and the chaotic genomic architecture
that results can inactivate or disrupt the transcription of many
more genes.
DISCUSSION
Here we describe a quite remarkable phenomenonwhereby tens
to hundreds of chromosomal rearrangements involving localized
genomic regions can be acquired in an apparently one-off
cellular catastrophe. Astoundingly, not only can a cell actually
survive this crisis, it can emerge with a genomic landscape
that confers a significant selective advantage to the clone,
promoting the evolution toward cancer. Such an event appears
to have occurred in 2%–3% of all cancers, across many
subtypes, and may be particularly frequent in bone cancers.38 Cell 144, 27–40, January 7, 2011 ª2011 Elsevier Inc.There are few documented examples of how catastrophic
genomic change affects evolutionary processes. Reassortment
of influenza virus genomes can lead to entirely novel strains
with considerable pandemic potential (Neumann et al., 2009).
In eukaryotes, ‘‘showers’’ of several pointmutations in a localized
genomic region in a single cell cycle have been described in
murine models (Wang et al., 2007), with similar arguments
extended to clustered mutations in humans with germline
genetic diseases (Chen et al., 2009). We would predict that in
the case of chromothripsis, the overwhelming majority of cells
suffering such spectacular genomic damage would either die
or acquire more detrimental than advantageous variants.
However, very rarely, a cell might acquire one or more cancer-
causing lesions from such an event and this clone would then
have taken a considerable leap along the road to cancer. There
would still be the need for additional mutations in cancer genes,
exemplified by the second hits inCDKN2A seen in the chordoma
and thyroid cancer samples (Figure 7), but we might anticipate
the emergent tumor having shorter latency.
What causes such dramatic damage to the genome? The
distinctive signature of the process gives some clues. The
genomic regions involved in each example are sharply circum-
scribed, whether it be a whole chromosome, a chromosome
arm or a region of just a few megabases within a chromosomal
band. It seems likely that the insult occurs while the chromo-
somes are condensed for mitosis. During interphase, chromo-
somes are relaxed with long loops of DNA winding through the
nucleus: although given chromosomes occupy general nuclear
territories, these tend to be loosely defined and nonexclusive
(Misteli, 2007). DNA damage acquired in interphase would
seem unlikely to exhibit such intense clustering of breaks within
suchwell-circumscribed genomic regions. The existence of rear-
rangements involving both sides of a DNA break, the potential to
create both a derivative chromosome and a double minute chro-
mosome in the same event and the seeming near-randomness of
which fragment is joined to which fragment suggest that literally
hundreds of shards of genomic DNA circulate unfettered in the
nucleus during the catastrophe, that the DNA repair machinery
is pasting them together in a helter-skelter tumult of activity.
The agent of this physical chromosomal damage is unknown.
One appealing possibility is ionizing radiation. Well-known to
induce dsDNA breaks, a pulse of ionizing radiation could cut
a swathe through a condensed chromosome and, depending
on whether the angle of the path relative to the long axis of the
chromosome is transverse, oblique or longitudinal, generate
breaks involving a band, an arm or the whole chromosome.
Such a model could potentially be tested by in vitro studies of
cells surviving irradiation and by analysis of cancer genomes
from patients with prior environmental or therapeutic radiation
exposure.
Another intriguing possibility is that the breakage-fusion-
bridge cycle associated with telomere attrition could induce
the damage, especially because most examples of chromothrip-
sis observed here involve regions extending to the telomeres
(Figure S1). End-to-end chromosome fusions are a cytogenetic
hallmark of telomere loss (Artandi et al., 2000; Gisselsson
et al., 2001; O’Hagan et al., 2002), and the two centromeres of
such dicentric chromosomes are pulled to opposite daughter
cells during anaphase, forming a so-called anaphase bridge
(Bignell et al., 2007; McClintock, 1941; Sahin and Depinho,
2010). It is unclear how these bridges are resolved, but they
appear to induce the formation of nuclear buds and micronuclei
containing fragmented DNA in the daughter cells (Pampalona
et al., 2010). It is therefore conceivable that the dramatic stretch-
ing and pinching of the chromosome bridge during the final
stages of cytokinesis could be associated with catastrophic,
but localized, genomic damage. If this hypothesis is true, cancer
genomes from genetically engineered mouse models of
telomerase deficiency (Artandi et al., 2000; Maser et al., 2007;
O’Hagan et al., 2002) may demonstrate similar patterns of
genomic rearrangement to those observed here.
Whatever the mechanism of damage, the consequences are
profound. Faced with hundreds of DNA breaks, the cell’s DNA
repair machinery attempts to rescue the genome. The resultant
hodgepodge bears little resemblance to its original structure,
and the genomic disruption has wholesale and potentially
oncogenic effects.
EXPERIMENTAL PROCEDURES
Samples
Rearrangement screens were performed on genomic DNA from 10 patients
with chronic B cell lymphocytic leukemia attending Addenbrooke’s Hospital,
Cambridge, UK. Screens were also performed on genomic DNA samples
from 20 patients with bone cancer (9 osteosarcoma, 11 chordoma) collected
at the Royal National Orthopaedic Hospital, Middlesex, UK. From all 30
samples, we had germline DNA available. Informed consent was obtained
from all patients or guardians and samples were collected and analyzed with
approval from relevant Ethics Committees. The cell line set has previously
been described (Bignell et al., 2010), and for the four samples presented
here, germline DNA was not available.
Massively Parallel Sequencing
The protocols for massively parallel, paired-end sequencing to identify somat-
ically acquired genomic rearrangements in cancer samples have been
described in detail elsewhere (Campbell et al., 2008; Quail et al., 2008;
Stephens et al., 2009). In brief, 5 mg of genomic DNA from the tumor sample
was sheared to fragments 400–500 base pairs (bp) in size. Sequencing of
37 bp from either end was performed on the Illumina Genome Analyzer II plat-
form. Reads were aligned to the reference human genome (NCBI build 36)
using MAQ (Li et al., 2008). Putative genomic rearrangements were screened
by PCR across the breakpoint in tumor DNA samples and, where available,
germline DNA.
SNP Array Analyses
Tumor DNA samples from the 20 patients with bone cancer and the cell line set
were also analyzed by Affymetrix SNP6 microarrays, as described (Bignell
et al., 2010). Copy number and allelic ratio profiles were statistically processed
using the PICNIC algorithm (Greenman et al., 2010).
Multiplex-Fluorescence In Situ Hybridization
Human 24 color M-FISH paint was made essentially following the ‘‘pooling’’
strategy described (Geigl et al., 2006). Briefly, individual human chromo-
some-specific DOP-PCR products were grouped into five re-amplifiable pools
based on the fluorescence label and subsequently labeled with biotin-16-
dUTP, Texas Red-12-dUTP, Cy3-, Cy5-dUTP, and Green-dUTP. Labeled
DNA was precipitated with human Cot-1 DNA. Where used, human fosmid
clones were selected according to their positions in the hg17 reference
assembly. Biotin-labeled probe was detected with one layer of Cy5.5-conju-
gated mouse anti-biotin. Metaphases were examined with either a Leica
DM5000 or a Zeiss AxioIamger D1 fluorescence microscope.Statistical Analysis
Simulations of the progressive rearrangement model were performed 1000
times using the 239 rearrangements involving chromosome 15 identified in
SNU-C1. Starting with a wild-type chromosome 15, rearrangements were
randomly selected without replacement from the set of 239 events. At each
step, the relevant rearrangement was applied to the current configuration of
the chromosome: for example, a deletion-type rearrangement would lead to
loss of intervening sequence between the breakpoints. Where the selected
rearrangement was impossible (that is, one breakpoint occurred in a region
already lost to the chromosome in that simulation), it was discarded and
another selected. Where more than one copy of the breakpoint location
existed in the current configuration (for example, the region had undergone
tandemduplication in a previous rearrangement), which copy of the breakpoint
location to use was chosen randomly. The number of unique copy number
states across the chromosome was monitored for each simulation.
To test whether the locations of genomic breakpoints showed more
clustering than expected by chance, Kolmogorov-Smirnov tests were used
to compare the observed distribution of distances between adjacent breaks
and that expected under the null hypothesis (exponential distribution).
For analysis of expression levels of genes from chromothripsis chromo-
somes compared to intact chromosomes, the expression levels of every
gene on the relevant chromosomes were converted to Z-scores using the
expression levels for other cell lines from the same tumor type. The distribution
of Z-scores for the chromothripsis chromosome was then compared to the
distribution for other chromosomes by the Kolmogorov-Smirnov test.
The circle plots were generated with Circos (Krzywinski et al., 2009).
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